SURMODICS INC SRDX Income Statement

Surmodics inc (SRDX)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Jun'10
Revenue:
Total revenue
100,598	100,452	100,077	92,299	90,182	86,564	81,336	78,356	73,919	72,364	73,112	71,208	73,390	72,586	71,366	70,576	66,518	64,234	61,898	59,870	58,572	57,761	57,439	56,400	56,073	56,164	56,132	55,678	55,348	53,863	51,928	51,986	51,026	52,150	52,756	57,463	0	0	0
Operating costs and expenses:
Product costs
13,995	13,319	13,639	14,069	14,809	14,629	13,997	13,226	12,036	11,685	11,422	10,943	10,806	11,170	10,908	10,657	10,054	9,083	8,619	8,310	8,173	7,914	8,016	7,741	7,694	7,943	7,898	7,856	8,117	7,787	7,418	7,492	6,543	6,777	6,750	7,102	0	0	0
Research and development
51,921	53,541	52,885	50,952	47,409	44,628	40,973	38,095	36,244	33,678	31,817	27,408	24,174	20,834	18,498	17,521	16,688	16,223	16,165	15,901	15,696	15,427	15,550	15,422	15,776	15,416	15,079	14,635	14,129	13,867	14,143	14,446	14,850	15,138	14,005	14,435	0	0	0
Customer research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Selling, general and administrative
26,801	24,944	23,950	23,270	23,308	24,872	24,111	22,913	22,168	20,804	20,478	20,186	19,437	19,214	18,000	16,502	15,891	15,012	14,906	14,343	14,062	14,382	14,691	14,043	14,504	14,057	13,859	15,305	14,665	14,212	14,025	14,404	14,525	14,604	14,862	15,674	0	0	0
Acquired in-process research and development
-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquired intangible asset amortization
2,330	2,393	2,405	2,422	2,447	2,479	2,491	2,507	2,486	2,441	2,419	2,272	2,475	2,664	2,422	2,106	1,451	822	619	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contingent consideration gain
-	-	-161	1,433	1,435	-478	675	-1,552	-2,287	554	-127	1,639	2,823	1,820	1,492	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition transaction, integration and other costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,187	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,616	0	0	0	-
Asset impairment charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Total operating costs and expenses
96,128	94,961	93,608	92,146	97,296	94,018	90,135	84,299	71,869	69,162	66,009	60,437	57,765	56,398	54,507	53,534	50,216	46,240	42,809	39,613	38,839	38,480	38,863	37,682	38,450	37,892	37,312	37,796	36,911	35,866	35,586	37,349	36,925	37,526	37,233	42,653	0	0	0
Operating (loss) income
4,470	5,491	6,469	153	-7,114	-7,454	-8,799	-5,943	2,050	3,202	7,103	10,771	15,625	16,188	16,859	17,042	16,302	17,994	19,089	20,257	19,733	19,281	18,576	18,718	17,623	18,272	18,820	17,882	18,437	17,997	16,342	14,637	14,101	14,624	15,523	14,810	0	0	0
Other (expense) income:
Investment income, net
976	1,031	1,097	1,135	1,169	1,046	851	682	483	426	390	301	216	147	63	43	60	100	156	193	199	209	238	274	292	282	268	310	387	474	540	547	557	581	627	739	0	0	0
Interest expense
148	155	152	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign exchange (loss) gain
-84	-49	134	225	919	561	239	-270	-1,516	-1,364	-504	-267	561	328	-481	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment loss on strategic investment
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	0
Gains on strategic investments and other
-	-	-	-	-	-	177	0	0	0	-	-	-	-	-	0	0	-	-	-	-	-	842	1,883	681	800	1,293	0	0	0	-	-	-	-	-	-	-	-	-
Other
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	0	-	-	0	0	-	228	343	549	0	-	0	0	-	0
Other investment capital gains
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-
Other (expense) income
267	831	1,089	1,257	2,023	1,577	1,267	633	-812	-717	-70	170	923	982	89	-1,421	-1,688	-1,032	-848	-487	-413	-821	-104	1,049	1,041	1,059	1,540	1,697	1,774	1,066	-36	-85	94	968	1,006	-1,161	0	0	0
(Loss) income before income taxes
4,737	6,322	7,558	1,410	-5,091	-5,877	-7,532	-5,310	1,238	2,485	7,033	10,941	16,548	17,170	16,948	15,621	14,614	16,962	18,241	19,770	19,320	18,460	18,472	19,767	18,664	19,331	20,360	19,579	20,211	19,063	16,306	14,552	14,195	15,592	16,529	13,649	0	0	0
Income tax benefit
-1,893	-108	-34	-875	-3,228	-4,286	-3,075	-3,006	140	2,415	3,107	4,838	7,231	7,538	6,963	6,855	5,858	5,976	6,294	6,737	6,537	6,269	6,265	6,271	5,664	5,370	5,781	5,879	6,515	6,841	6,177	5,087	4,853	5,372	5,604	5,830	0	0	0
Income from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-	10,129	9,465	9,342	10,220	10,925	0	0	0	-
Loss from discontinued operations, net of income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-	1,176	-19,624	-18,803	-18,795	-29,431	0	0	0	-
Loss on sale of discontinued operations, net of income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,074	0	0	0	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	102	-20,639	-19,736	-19,849	-29,431	0	0	0	-
Net income
6,630	6,430	7,592	2,285	-1,863	-1,591	-4,457	-2,304	1,098	70	3,926	6,103	9,317	9,632	9,985	8,766	8,756	10,986	11,947	12,933	12,607	12,015	12,031	13,373	12,906	14,549	15,167	14,221	14,152	11,773	10,231	-11,174	-10,394	-9,629	-18,506	-757	0	0	0
Basic income (loss) per share:
Continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.27	-	-	-	0.22	0.23	-	0.17	0.18	0.11	0.12	0.14	0.17	0.16	0.16	-
Discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.01	-	-	-	0.00	0.05	-	0.00	-0.01	-0.01	0.03	-1.20	0.05	-0.02	-0.52	-
Basic net income per share
0.11	0.01	0.27	0.11	0.09	0.10	-0.14	-0.20	0.12	-0.12	0.04	0.05	0.04	0.17	0.21	0.30	0.06	0.20	0.11	0.30	0.24	0.27	0.18	0.26	0.18	0.26	0.26	0.22	0.28	0.29	0.17	0.17	0.10	0.15	-1.06	0.22	0.14	-0.36	-0.05
Diluted income (loss) per share:
Continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.27	-	-	-	0.22	0.23	-	0.17	0.18	0.11	0.12	0.14	0.17	0.16	0.16	-
Discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.01	-	-	-	0.00	0.05	-	0.00	-0.01	-0.01	0.03	-1.20	0.05	-0.02	-0.52	-
Diluted net income per share
0.11	0.01	0.26	0.11	0.09	0.09	-0.13	-0.20	0.11	-0.12	0.03	0.05	0.04	0.17	0.20	0.30	0.06	0.20	0.10	0.30	0.23	0.27	0.17	0.26	0.18	0.26	0.25	0.21	0.28	0.29	0.17	0.17	0.10	0.15	-1.07	0.22	0.14	-0.35	-0.05
Weighted average number of shares outstanding:
Basic
13,507	13,469	13,405	13,394	13,390	13,367	13,259	13,203	13,102	13,064	13,037	13,155	13,220	13,200	13,062	12,995	12,969	12,966	12,945	13,002	12,944	13,225	13,649	13,585	13,538	13,756	14,166	14,413	14,622	14,655	16,749	17,528	17,519	17,476	17,449	17,437	17,407	17,383	17,360
Diluted
13,751	13,769	13,778	13,726	13,785	13,827	12,896	13,203	13,465	13,064	13,297	13,385	13,428	13,446	13,216	13,284	13,190	13,186	13,247	13,279	13,207	13,423	13,858	13,813	13,824	14,009	14,408	14,739	14,914	14,863	16,917	17,647	17,632	17,528	17,451	17,529	17,471	17,397	17,360
Product Sales [Member]
Total revenue
42,325	40,442	40,219	40,212	40,817	39,616	37,953	0	33,927	33,177	32,790	32,097	31,282	31,519	30,999	29,710	28,781	26,259	24,925	24,247	23,731	23,245	22,798	22,450	21,960	22,553	22,506	21,981	22,152	21,461	20,742	21,056	20,274	20,335	20,150	20,312	0	0	0
Royalties and License Fees [Member]
Total revenue
46,799	48,510	48,458	41,975	39,948	38,444	35,424	0	31,971	30,862	31,787	30,560	33,872	33,250	33,203	34,404	31,756	32,442	31,763	30,664	30,141	30,087	30,277	29,659	30,101	29,723	29,774	29,742	29,019	28,351	27,445	27,744	28,118	29,478	30,385	31,994	0	0	0
Research, Development and Other [Member]
Total revenue
11,474	11,500	11,400	10,112	9,417	8,504	7,959	7,957	8,021	8,325	8,535	8,551	8,236	7,817	7,164	6,462	5,981	5,533	5,210	4,959	4,700	4,429	4,364	4,291	4,012	3,888	3,852	3,955	4,177	4,051	3,741	3,186	2,634	2,337	2,221	-1,809	0	0	0